腹腔内高压与腹腔间隔室综合征:你需要知道什么
腹腔内高压是重症患者常见的病理性腹内压升高,是发病率和死亡率的独立预测因子,一旦进展为腹腔间隔室综合征则预后极差、死亡率极高。腹内压病理性升高可直接和间接引起多器官系统生理改变,导致患者迅速恶化。诊断腹腔间隔室综合征虽为临床诊断,但单纯体格检查敏感性低,高危患者应每4小时监测膀胱压。治疗选择取决于腹内压或器官功能的变化及其发展时间,阶梯式管理从微创支持和药物治疗开始,必要时升级至操作和手术干预。
要点
- 高危患者应每4小时测量膀胱压以监测腹腔内压,因单纯体格检查诊断腹腔间隔室综合征的敏感性低。
- 腹腔内高压本身是发病率和死亡率的独立预测因子,进展为腹腔间隔室综合征后即使治疗死亡率也极高。
- 腹内压病理性升高可直接和间接影响多器官系统,可导致患者迅速恶化,需尽早识别高危患者。
- 治疗选择取决于腹内压或器官功能的变化及其发展时间,阶梯式管理从微创支持和药物治疗开始,按需升级至操作和手术干预。
- 腹腔内高压的管理策略包括减少腹腔内容量、增加腹壁顺应性和优化液体平衡,后者在重症患者中需细致权衡。
适用人群与场景
- 最常见于有进展为腹腔间隔室综合征倾向的重症患者,一旦发生器官功能障碍即提示进展。
- 重症监护提供者需识别需要监测腹腔内压的高危患者。
诊断标准与关键阈值
- 腹腔间隔室综合征的诊断是临床诊断。
- 高危患者应进行腹腔内压监测,每4小时测量膀胱压。
处置流程与药物剂量
- 腹腔内高压的管理策略聚焦于减少腹腔内容量、增加腹壁顺应性和优化液体平衡,后者在重症患者中需细致权衡。
- 阶梯式管理方法建议从创伤较小的支持和药物治疗开始,视情况升级至操作干预,必要时再行手术干预以降低病理性升高的腹腔内压。
- 治疗选择取决于腹腔内压或器官功能的变化以及这些变化发展所经历的时间。
- 腹腔内高压涵盖从无症状的腹内压升高到需要紧急减压的显性腹腔间隔室综合征,可选用多种治疗选项。
红旗征与不能漏的情况
- 进展为腹腔间隔室综合征提示预后更差,即使治疗后死亡率也极高。
- 腹内压病理性升高可引起多器官系统生理改变,可能导致患者迅速恶化。
- 显性腹腔间隔室综合征需要紧急减压。
证据类型、等级与局限
- 局限:原文未报告局限性
对床旁实践的改变
- 重症监护提供者需能识别需要腹腔内压监测的患者、识别并处理腹腔内高压相关的生理改变、并有效管理该病以预防腹腔间隔室综合征的潜在灾难性后果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「研究设计与关键结果」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Abdominal hypertension is a pathologic elevation in intraabdominal pressure most often seen in critically ill patients with propensity for progression to abdominal compartment syndrome once organ dysfunction develops. Intraabdominal hypertension alone is an independent predictor of morbidity and mortality, but progression to abdominal compartment syndrome portends a worse prognosis with extremely high mortality rates, even after treatment. Pathologic increases in intraabdominal pressure can cause physiologic changes impacting multiple organ systems both directly and indirectly, which may lead to rapid patient deterioration. As such, critical care providers must be able to identify high risk patients in order to effectively monitor intraabdominal pressure and to provide expeditious, appropriate treatment for these patients when warranted. While the diagnosis of abdominal compartment syndrome is clinical, the sensitivity of physical examination alone is low, and at risk patients should undergo intraabdominal pressure monitoring with bladder pressures measured every 4 hours. Changes in intraabdominal pressure or organ function and the time over which these changes develop dictate treatment choice. Management strategies for intraabdominal hypertension focus on reduction of intraabdominal volume, increasing abdominal wall compliance, and optimizing fluid balance, which is a nuanced practice in critically ill patients. There are a multitude of treatment options which may be employed to address the spectrum of intraabdominal hypertension, which ranges from asymptomatic elevations in intraabdominal pressure to overt abdominal compartment syndrome requiring emergent decompression. The step-up management approach suggests beginning with less invasive supportive and medical therapies and escalating as appropriate to procedural, then surgical interventions if necessary to reduce pathologically elevated intraabdominal pressure. To improve patient outcomes, critical care providers must be adept at identifying patients requiring intraabdominal pressure monitoring, recognizing and addressing physiologic changes associated with intraabdominal hypertension, and managing the condition effectively to prevent the potentially catastrophic consequences of abdominal compartment syndrome.
参考来源
- Arcieri TR, Meizoso JP. Intraabdominal hypertension and abdominal compartment syndrome: What you need to know. J Trauma Acute Care Surg. 2025. PMID: 40189748. doi:10.1097/TA.0000000000004603
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。